News | September 10, 2008

Good Samaritan Health System Among First to Implant Advanced Defibrillator

September 11, 2008 - Good Samaritan Hospital was among the first in the nation to implant a TELIGEN implantable cardioverter defibrillator (ICD) made by Boston Scientific.

This advanced device is used to treat sudden cardiac death, which is the abrupt loss of heart function, usually due to an electrical rhythm dysfunction in the lower chambers of the heart that causes the heart to pump blood ineffectively.

GSH is among the first to bring this new technology to Central Pennsylvania. Dr. Jeffrey L. Williams, M.D., MS, FACC, implanted the devices in two patients on Aug. 7. This device represents an entirely new platform to treat sudden cardiac death and provides physicians enhanced clinical options for their patients. It is one of the smallest, thinnest implantable defibrillators in the world, featuring innovative new technologies with exceptional longevity.

“Our goal is provide the most state-of-the-art heart rhythm services with a patient- and family-centered care giving approach. We are proud to offer these services to our patients at Good Samaritan Hospital,” said Dr. Williams.

Good Samaritan Hospital’s Cardiac Catheterization Laboratories had an impressive overall Press-Ganey patient satisfaction score of 93.4 percent (from January through March 2008). In addition, Good Samaritan Hospital was awarded an American Heart Association Get With the Guidelines Heart Failure (GWTG–HF) Silver Performance Achievement Award. The award signifies that the hospital reached an aggressive goal of treating heart failure patients based on core standard levels of care as outlined by the AHA/American College of Cardiology.

For more information: www.lebanoncardiology.com, www.gshleb.org

Related Content

Medtronic Begins Pilot Study of Investigational Extravascular ICD System
News | Implantable Cardioverter Defibrillator (ICD) | August 09, 2018
Medtronic plc announced the start of a pilot study of its investigational Extravascular Implantable Cardioverter...
ICD Placements Not Meeting Medicare Coverage Criteria Decline After Overuse Investigation Announced
Feature | Implantable Cardioverter Defibrillator (ICD) | July 11, 2018
Placement of implantable cardioverter defibrillators (ICDs) not meeting Centers for Medicare and Medicaid Services (CMS...
New Tool Predicts Benefits and Risks of Implantable Defibrillator for Heart Failure Patients
News | Implantable Cardioverter Defibrillator (ICD) | July 02, 2018
University of Washington (UW) Medicine cardiologists have developed a tool to predict which heart-failure patients...
Real-World Data Demonstrates Success Of Smart Pass Filter on Boston Scientific S-ICD System
News | Implantable Cardioverter Defibrillator (ICD) | May 16, 2018
Boston Scientific announced results from an analysis of the LATITUDE database evaluating the successful reduction of...
Online Message Board Advice on ICDs Reflects Inaccuracies
News | Implantable Cardioverter Defibrillator (ICD) | April 13, 2018
April 13, 2018 — Medical advice about implanted cardiac defibrillators obtained via an online message board appears t
Biotronik U.S. to Distribute Aziyo ECM Envelopes
News | Implantable Cardioverter Defibrillator (ICD) | April 12, 2018
Biotronik U.S. and Aziyo announced a strategic agreement allowing Biotronik to distribute Aziyo's CanGaroo...
Boston Scientific Launches Resonate Devices With HeartLogic Heart Failure Diagnostic
Technology | Implantable Cardioverter Defibrillator (ICD) | September 27, 2017
September 27, 2017 — Boston Scientific recently launched the Resonate family of...
Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD) | September 22, 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Predictive Models May Help Determine Which Patients Benefit From ICDs
News | Implantable Cardioverter Defibrillator (ICD) | July 06, 2017
Two predictive models may help cardiologists decide which patients would most benefit from an implantable cardioverter...
Videos | Implantable Cardioverter Defibrillator (ICD) | June 01, 2017
Lucas Boersma, M.D., Ph.D., FESC, St.
Overlay Init